BR0107767A - Vacinas dna melhoradas para animais de renda - Google Patents

Vacinas dna melhoradas para animais de renda

Info

Publication number
BR0107767A
BR0107767A BR0107767-8A BR0107767A BR0107767A BR 0107767 A BR0107767 A BR 0107767A BR 0107767 A BR0107767 A BR 0107767A BR 0107767 A BR0107767 A BR 0107767A
Authority
BR
Brazil
Prior art keywords
animals
income
dna vaccines
carbon atoms
improved dna
Prior art date
Application number
BR0107767-8A
Other languages
English (en)
Inventor
Jean-Christophe Franc Audonnet
Laurent Bernard Fischer
Simona Barzu-Le-Roux
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Sas filed Critical Merial Sas
Publication of BR0107767A publication Critical patent/BR0107767A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"VACINAS DNA MELHORADAS PARA ANIMAIS DE RENDA". A invenção refere-se a uma vacina DNA contra um patógeno referente aos animais de renda, notadamente os bovinos ou os suínos, compreendendo um plasmídeo contendo uma seq³ência nucleotídica codificando para um imunógeno de um patógeno da espécie animal considerada, em condições que permitem a expressão in vivo dessa seq³ência, e um lipídio catiónico, contendo um sal de amónio quaternário, de fórmula (I), na qual R~ 1~ é um radical alifático linear, saturado ou insaturado, tendo de 12 a 18 átomos de carbono, R~ 2~ é um outro radical alifático, contendo 2 ou 3 átomos de carbono e X é um grupamento hidroxila ou amina, esse lipídeo sendo, de preferência, o DMRIE.
BR0107767-8A 2000-01-21 2001-01-19 Vacinas dna melhoradas para animais de renda BR0107767A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0000798A FR2804028B1 (fr) 2000-01-21 2000-01-21 Vaccins adn ameliores pour animaux de rente
PCT/FR2001/000187 WO2001052888A2 (fr) 2000-01-21 2001-01-19 Vaccins adn ameliores pour animaux de rente

Publications (1)

Publication Number Publication Date
BR0107767A true BR0107767A (pt) 2002-11-12

Family

ID=8846183

Family Applications (2)

Application Number Title Priority Date Filing Date
BR0107767-8A BR0107767A (pt) 2000-01-21 2001-01-19 Vacinas dna melhoradas para animais de renda
BRPI0107767-8A BRPI0107767B1 (pt) 2000-01-21 2001-01-19 Dna vaccines improved for animals of income

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0107767-8A BRPI0107767B1 (pt) 2000-01-21 2001-01-19 Dna vaccines improved for animals of income

Country Status (21)

Country Link
EP (1) EP1248650B1 (pt)
JP (1) JP2004500375A (pt)
KR (1) KR100820893B1 (pt)
CN (2) CN101554480A (pt)
AR (1) AR027926A1 (pt)
AT (1) ATE346611T1 (pt)
AU (1) AU783865B2 (pt)
BR (2) BR0107767A (pt)
CA (1) CA2398229C (pt)
CY (1) CY1107627T1 (pt)
DE (1) DE60124862T2 (pt)
DK (1) DK1248650T3 (pt)
ES (1) ES2277913T3 (pt)
FR (1) FR2804028B1 (pt)
HU (1) HU229597B1 (pt)
MX (1) MXPA02007110A (pt)
NZ (1) NZ520270A (pt)
PL (1) PL209304B1 (pt)
PT (1) PT1248650E (pt)
WO (1) WO2001052888A2 (pt)
ZA (1) ZA200205698B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
ES2429338T3 (es) 2002-12-23 2013-11-14 Vical Incorporated Vacuna basada en polinucleótidos optimizados por codones contra infección por citomegalovirus humano
BR0318114B1 (pt) * 2003-02-19 2014-09-02 Merial Ltd Vacinação ou imunização utilizando um regime de iniciação-reforço
EP1689858B1 (en) 2003-11-13 2013-05-15 University Of Georgia Research Foundation, Inc. Methods of characterizing infectious bursal disease virus
CU23544A1 (es) 2006-02-28 2010-06-17 Ct Ingenieria Genetica Biotech Antígenos vacunales quiméricos contra el virus de la peste porcina clásica
US7862821B2 (en) 2006-06-01 2011-01-04 Merial Limited Recombinant vaccine against bluetongue virus
BRPI1012811A2 (pt) * 2009-05-22 2016-03-29 Genocea Biosciences Inc vacinas contra o vírus herpes simplex tipo 2: composições e métodos para obtenção de uma resposta imune
JP2014500875A (ja) * 2010-11-19 2014-01-16 ベイジン カイン テクノロジー シェア−ホールディング シーオー．， エルティーディー． Ｂ型肝炎の予防及び治療のためのｄｎａワクチン組成物
CN112034169A (zh) * 2020-08-27 2020-12-04 华威特（江苏）生物制药有限公司 用于检测牛病毒性腹泻病毒1型的直接免疫荧光试剂及其试剂盒

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07504683A (ja) * 1992-07-08 1995-05-25 シェリング・コーポレーション Ｇｍ−ｃｓｆのワクチンアジュバントとしての利用
JPH09500013A (ja) * 1993-06-01 1997-01-07 ライフ・テクノロジーズ・インコーポレイテッド カチオン性脂質による遺伝子免疫
US5658785A (en) * 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
EP0779923A2 (en) * 1994-09-09 1997-06-25 Neurocrine Biosciences, Inc. Interleukin-1 type 3 receptors
US5736524A (en) * 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5719131A (en) * 1994-12-09 1998-02-17 Genzyme Corporation Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
JPH11504631A (ja) * 1995-04-25 1999-04-27 バイカル インコーポレイテッド Ｄｎａ／脂質複合体の単一バイアル製剤
EP0833613A1 (en) * 1995-05-26 1998-04-08 Somatix Therapy Corporation Delivery vehicles comprising stable lipid/nucleic acid complexes
FR2751229B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751224B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751228B1 (fr) * 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
WO1998040499A1 (en) * 1997-03-10 1998-09-17 Heather Lynn Davis Gene delivery to mucosal epithelium for immunization or therapeutic purposes
AUPO856097A0 (en) * 1997-08-14 1997-09-04 Commonwealth Scientific And Industrial Research Organisation Vector
US6943152B1 (en) * 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
WO2000077043A2 (fr) * 1999-06-10 2000-12-21 Merial Vaccins adn pour animaux de compagnie et de sport

Also Published As

Publication number Publication date
KR100820893B1 (ko) 2008-04-10
CA2398229C (en) 2012-05-15
FR2804028A1 (fr) 2001-07-27
EP1248650A2 (fr) 2002-10-16
ATE346611T1 (de) 2006-12-15
DE60124862T2 (de) 2007-07-05
CN101554480A (zh) 2009-10-14
DE60124862D1 (de) 2007-01-11
CY1107627T1 (el) 2013-04-18
KR20020084093A (ko) 2002-11-04
CN1404398B (zh) 2012-05-02
ZA200205698B (en) 2003-09-29
PL209304B1 (pl) 2011-08-31
EP1248650B1 (fr) 2006-11-29
WO2001052888A3 (fr) 2001-12-20
HU229597B1 (en) 2014-02-28
NZ520270A (en) 2004-08-27
MXPA02007110A (es) 2003-01-28
JP2004500375A (ja) 2004-01-08
HUP0203974A2 (hu) 2003-03-28
ES2277913T3 (es) 2007-08-01
PL356554A1 (en) 2004-06-28
DK1248650T3 (da) 2007-04-16
FR2804028B1 (fr) 2004-06-04
CA2398229A1 (en) 2001-07-26
HUP0203974A3 (en) 2004-07-28
BRPI0107767B1 (pt) 2017-10-24
WO2001052888A2 (fr) 2001-07-26
CN1404398A (zh) 2003-03-19
AR027926A1 (es) 2003-04-16
PT1248650E (pt) 2007-02-28
AU783865B2 (en) 2005-12-15
AU3556601A (en) 2001-07-31

Similar Documents

Publication Publication Date Title
EA200301323A1 (ru) Однократная вакцинация mycoplasma hyopneumoniae
BR0107767A (pt) Vacinas dna melhoradas para animais de renda
NZ757210A (en) Oil-based adjuvants
BR9611623A (pt) Composição de vacina e processo para a profilaxia ou tratamento de infecção em um animal ou pássaro por lawsonia intracelularis ou microorganismo relacionado, molécula de ácido nucleico isolada, e, vacina genética.
ATE549032T1 (de) Adjuvanzverbindungen zur verbesserung von immunreaktionen auf polynukleotid-basierten impfstoffen
ES2118815T3 (es) Virus de la seudorrabia, s-prv-155, atenuado y obtenido por ingenieria genetica y sus usos.
BRPI0418317A (pt) vacina de aumento de crescimento à base de epitopo de neutralização
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
EA200301324A1 (ru) Вакцина mycoplasma bovis и способы сокращения пневмонии у животных
BR9909483A (pt) Derivados de proteìnas ligantes pneumococcal colina para vacinas
ATE255419T1 (de) Für den vogelembryo geeignete multivalente impfstoffe
MXPA03011924A (es) Vacuna de micoplasma hyopneumoniae y metodos para reducir la neumonia por mycoplasma bovis en el ganado.
BRPI0417076A (pt) produção da toxina da difteria
BR0011732A (pt) Vacinas de dna para animais de companhia e de esporte
ES2155129T3 (es) Vacunacion in ovo contra la coccidiosis.
CY1108178T1 (el) Βακτηριο που προκαλει νοσο των πουλερικων και εμβολιο προερχομενο εξ' αυτου
ATE228016T1 (de) Lebendvakzine zur behandlung von tumorerkrankungen
BR0102134A (pt) Composição para ração para um animal de criação, ração, e, método para aumentar a eficiência de ganho de peso corpóreo e a eficiência de ração do animal de criação
BRPI0410332A (pt) vacina aviária de e. coli para proteção contra colibacilose
BR9814958A (pt) Proteìna de cimento de tecido, composição farmacêutica, uso da proteìna de cimento de tecido, vacina, processos para produção de vacina, para ligação de tecido de animal e para preparação de uma protéina de cimento de tecido, molécula de ácido nucleico, vetor de expressão ou de clonagem, célula hospedeira, e, animal transgênico
ES2078642T3 (es) Vacuna recombinante contra la enfermedad de marek.
BR9912548A (pt) Fator-11 de diferenciação de crescimento
BR0011289A (pt) Uso de genes das vias biossintéticas do desoxi-d-xilulose fosfato para a alteração da concentração de isoprenóide
BR9906761A (pt) Formulação de vacina de ácidos nucleicos e acemanano.
FR2809960B1 (fr) Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O C/C 13 E 25 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 22A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2706 DE 16-11-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.